Published September 1996 | Version v1
Journal article

High-dose rate intracavitary irradiation using linear source arrangement for squamous cell carcinoma of the uterine cervix

Description

Purpose: To evaluate the results of fractionated high-dose-rate (HDR) intracavitary irradiation using a linear source arrangement (LSA) without vaginal ovoids for patients with squamous cell carcinoma of the uterine cervix. Methods and Materials: From 1980 to 1990, 236 patients with squamous cell carcinoma received external beam therapy (EBT) followed by fractionated HDR intracavitary irradiation using LSA (HDR-LSA). The initial FIGO stage was I, II, and III for 19, 71, and 146 patients respectively. Forty Gy in 20 fractions (40 Gy/20 Fr) were delivered to the whole pelvis and additional 10 Gy/5 Fr to the center shielding field with parallel opposed ports. The HDR-LSA dose was 30 Gy/6 Fr or 35 Gy/7 Fr at Manchester's point A giving two fractions per week. During the intracavitary irradiation, patients were treated in the out-patient clinic. A vaginal plastic applicator was inserted with lubricating gel without spinal or general anesthesia and gauze packing. Results: Pelvic failure rate was 10.5% for stage I, 12.7% for stage II, and 35.6% for stage III. Cause-specific 5-year survival rates were 69.1% for stage I, 77.1 % for stage II, and 50.1 % for stage III, respectively. The low survival for stage I disease was suggested to be due to selection bias. In multivariant analyses, stage (stage I+II vs. III, p=0.0003), pre-treatment serum hemoglobin level (p=0.0021), pre-treatment serum total protein level (p=0.0028), and total treatment time (p=0.0035) were significantly associated with cause-specific survival. The rate of late severe complications was 2.1% for rectum, 1.2% for small intestine, and 1.3 % for bladder. Conclusions: The LSA-HDR method following EBT is a safe and effective technique for the majority of patients. Reproducibility of dose distribution and the easiness of the insertion for the patients are suitable for multi-fractionated schedule required in HDR treatment. The benefit of the LSA, compared to the arrangement using a tandem and ovoids, should be reappraised in the light of patient comfort, biological importance of multi-fractionation, and the compatible treatment results of the present study

Additional details

Identifiers

PII
S0360301697856593;

Publishing Information

Journal Title
International Journal of Radiation Oncology, Biology and Physics
Journal Volume
36
Journal Issue
1
Journal Page Range
p. 318
ISSN
0360-3016
CODEN
IOBPD3

Conference

Title
38. annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO)
Dates
27-30 Oct 1996
Place
Los Angeles, CA (United States)

INIS

Country of Publication
United States
Country of Input or Organization
International Atomic Energy Agency (IAEA)
INIS RN
34060622
Subject category
S62: RADIOLOGY AND NUCLEAR MEDICINE;
Resource subtype / Literary indicator
Conference
Descriptors DEI
CARCINOMAS; DOSE RATES; FRACTIONATED IRRADIATION; INTERNAL IRRADIATION; RADIATION SOURCE IMPLANTS; SURVIVAL CURVES; UTERUS
Descriptors DEC
BODY; DISEASES; FEMALE GENITALS; IMPLANTS; IRRADIATION; NEOPLASMS; ORGANS; RADIATION SOURCES

Optional Information

Copyright
Copyright (c) 1996 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.